July 28, 2008
NASHVILLE, TN – Centerre Healthcare Corporation, a national provider of inpatient acute rehabilitation services, recently hired Douglas Johnson as senior vice president of development. Mr. Johnson will be responsible for all activities related to securing quality development partnerships with large Medical-Surgical hospital systems to bring acute medical rehabilitation programs to communities that promote the recovery of individuals who have functional deficits resulting from injury or illness.
Read More…
July 17, 2008
Raven’s Discovery Platform in Cancer Stem Cell Biology Enhances MacroGenics’ Oncology Capabilities and Complements Proprietary Antibody Technology Platforms
ROCKVILLE, MD — MacroGenics, Inc, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the acquisition of Raven Biotechnologies, Inc., a privately held biotechnology company in South San Francisco, California, focused on the discovery and development of monoclonal antibody therapeutics for oncology through its cancer stem cell program.
Read More…
June 24, 2008
Multi-Disciplinary Oversight Panel Includes American Brachytherapy Society, American Society of Breast Surgeons and American College of Radiation Oncology
SUNNYVALE, CA. – Xoft, Inc. today announced the launch and of the EXIBT Study (Electronic Xoft Intersociety Brachytherapy Trial), a national Electronic Brachytherapy patient registry under oversight from three national physician societies, the American Brachytherapy Society (ABS), the American Society of Breast Surgeons (ASBrS), and the American College of Radiation Oncology (ACRO). The first patient was successfully enrolled and treated in the registry by Drs. Peter Beitsch of the Dallas Breast Center and Dr. Timothy Nichols of the Northpoint Cancer Center in Dallas, Texas.
Read More…
June 19, 2008
SEATTLE, WA -— Calypso® Medical Technologies, Inc. announced today that Eric R. Meier, president and CEO, was named the Ernst & Young Entrepreneur Of The Year® 2008 Pacific Northwest award recipient in the Health Services and Life Sciences category. The award recognizes outstanding entrepreneurs who are building and leading dynamic and growing businesses. Meier was selected by an independent panel of judges and the award was presented at an Ernst & Young Entrepreneur Of The Year gala on June 13, 2008 in Seattle, WA.
Read More…
June 16, 2008
SAN DIEGO, CA, — Patient enrollment into the GRAVITAS (Gauging Responsiveness With A VerifyNow® Assay-Impact On Thrombosis And Safety) trial has begun, officials from Accumetrics announced today. The GRAVITAS trial is designed to evaluate the use of the VerifyNow P2Y12 test to identify patients that exhibit a low response to antiplatelet therapy who are at risk for adverse cardiac events, and prove that these at-risk patients will benefit from tailored antiplatelet therapy.
Read More…
